SUMMARY The cross-reaction of IgM-rheumatoid factors (IgM-RF) with a cell nuclear antigen has been further investigated by immunofluorescence procedures. This reaction appears to be optimal at pH 8-9, and fails to occur at pH 6. The apparent cross-reaction of RF with a cell nuclear antigen could be of immunopathological significance in RA, and this possibility has been explored by investigation of the pH and ionic strength requirements of this reaction, as well as of its complement-fixing potential.
Recent investigations have confirmed and extended an original observation by McCormick and Day'
that some rheumatoid factors (RF) appear to react with both IgG and a cell nuclear antigen.2 3 The occurrence ofthis cross-reacting antinuclear antibody (ANA) activity is high in isolated RF preparations,4 5 though it can be masked in the original seropositive serum and may often require purification of RF from serum for its manifestation. 46 The relevant cross-reactive nuclear antigen is present in nuclei of normal cells from many species, including man, and would appear to require some concomitant presence of both DNA and core histone proteins for its antigenic representation.4 7 8 The apparent cross-reaction of RF with a cell nuclear antigen could be of immunopathological significance in RA, and this possibility has been explored by investigation of the pH and ionic strength requirements of this reaction, as well as of its complement-fixing potential.
Materials and methods

IgM-RF PREPARATIONS
IgM-RF preparations were isolated from 5 seropositive RA sera of high titre by affinity chromatography using immobilised heat-aggregated human IgG, as described previously. Indirect immunofluorescence on cryostat sections of rat liver and kidney tissues was performed as described previously4 with the following modifications according to the experimental design. The pH sensitivity of the ANA reaction of isolated IgM-RF preparations was investigated by performing the first-layer antibody-binding reaction and washing wholly in PBS whose pH had been adjusted appropriately to points within the range pH 5*0-100 by addition of either 0 5 M HC1 or 0 5 M NaOH. In some experiments 0 05 M Tris-HC1 or 0 05 M Tris-NaOH buffers were also employed, both with 0-1 M NaCl added. The subsequent second-layer staining reaction with an appropriate dilution of fluorescein isothiocyanate (FITC)-conjugated antihuman Ig or IgM (Wellcome Reagents Ltd., Beckenham, Kent) and washing were performed wholly in PBS, pH 8 0.
The ionic strength sensitivity of the ANA reaction of isolated IgM-RF preparations was investigated by performing the first-layer antibody-binding IgM-rheumatoid factors cross-reactive with IgG and a cell nuclear antigen 587 reaction and washing wholly in PBS, pH 8-0, at 0*1, 0-33, 1-0, 3-0, and 10-0 x isotonic molarity. As before, the subsequent second-layer FITCconjugated antibody-staining reaction and washing were performed wholly in PBS, pH 8- 
Results
All isolated IgM-RF preparations showed optimal reactivity with a cell nuclear antigen in immunofluorescence when the binding reaction was performed in buffers at pH 8-9. No positive reaction was noted at pH 6 -5. A typical pH sensitivity profile for the ANA activity of IgM-RF is given in Table 1 . This contrasts with the optimal pH profile for whole IgM-ANA-positive RF-negative sera, which was determined to be pH 6 -0-8 -5. All isolated IgM-RF preparations showed optimal reactivity with a cell nuclear antigen in immunofluorescence when the reaction was performed in Table 2 . Similar optimal profiles for ionic strength were observed with whole IgM-ANApositive RF-negative sera. Evidence for complement fixation from GPS by IgM-RF bound to the cell nuclear antigen was sought by immunofluorescence. These experiments were consistently negative whereas most whole 1gM-ANA-positive RF-negative sera studied analogously showed clear complement fixation, manifest by positive nuclear staining for guinea-pig C3. Controls stained for human IgM rather than guinea-pig C3, after treatment of tissue sections with IgM-RF followed by GPS, showed that treatment with dilutions of GPS did not dissociate all IgM-RF from the nuclear antigen.
Discussion
In the absence of any data yet available comparing binding affinities of the reactions of RF with IgG and a cell nuclear antigen the immunopathological significance of the ANA activity of RF must be assessed by investigation of its optimal reaction conditions and of any biological sequelae following this reaction. Previous work has shown that the ANA activity of RF may often appear masked in whole seropositive serum,4 6 suggesting that this cross-reacting antibody specificity might be of significance only in a serum-depleted milieu such as following phagocytosis of RF-containing complexes. The present study has indicated a displacement to alkaline pH of the optimal reaction conditions for cell nuclear reactivity of IgM-RF compared with whole IgM-ANA-positive RF-negative sera. This could reflect either an unusual lability of the relevant cell nuclear antigenic structure to acidic pHs, even to pH 6 -5, or an unusual ionic contribution to the antigen-antibody interaction. Previous studies4 7 8 have indicated that the relevant cell nuclear antigen may be dependent on the presence of both the strongly anionic and cationic macromolecular components in the nuclear complex, and the unusual alkaline optimal pH of nuclear reactivity of RF may be clarified when further studies have defined the nature of the relevant cell nuclear antigen. The optimal ionic strength for cell nuclear reactivity of IgM-RF, at or below isotonic molarity, supports there being a significant ionic contribution to this interaction.
No evidence has been gained by immunofluorescence that IgM-RF bound to the cell nuclear antigen can fix complement. The above data taken together would indicate that the nuclear reactivity of IgM-RF may be of limited immunopathological significance in that the reaction (a) does not appear to result in complement fixation, (b) is optimal at pH 8-9, and (c) may often be inhibited by other serum components.
Finally, it is of note that IgM-rheumatoid factors in RA show a pronounced degree of antigenic homogeneity in their own immunoglobulin structure in terms oflight-chain antigens,9 heavy-chain variable region subgroup antigens,'0 and idiotypic antigens."
This restriction of molecular heterogeneity may be expected for antibody populations resulting from a chronic immunisation procedure. However, in marked contrast, IgM-rheumatoid factors in RA show a pronounced degree of antibody heterogeneity in terms of specificity for antigens on IgG from human and other species'2 as well as demonstrating certain unexpected cross-reactions. The most notable cross-reaction is that described with a cell nuclear antigen, but apparent cross-reactions with the haptenic dinitrophenyl and trinitrophenyl groups and with bacterial peptidoglycan have also been described.3'14 The reasons for this behavioural contrast of IgM-RF in RA remain unexplained.
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